23andMe Eliminates Subscription Model | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic testing service firm 23andMe has done away with its subscription model following pushback from its customers and genetic genealogists.

In a note to its subscribers on Tuesday 23andMe CEO Anne Wojcicki said, "We listened to your feedback and now understand that subscriptions were not good for you and thus not good for 23andMe."

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.

In Science this week: new chromatin imaging approach, and more.